Rituximab, gemcitabine and oxaliplatin are active as single agents in relapsed or refractory lymphoma, and have demonstrated synergistic effects in vitro and in vivo.

• 美罗华、吉西他滨和草酸铂是用来治疗复发或者难以控制的淋巴瘤病人的常用的单一药物，试验证明他们之间有协同作用。